• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

EBI-2511 Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5754813

EBI-2511 is a highly potent and orally active inhibitor of EZH2 (IC50: 6nM in Pfeffiera cell lines). More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
EBI-2511, Inhibitor
Full Product Name
EBI-2511
Product Gene Name
Form/Format
Solid. Powder
Purity/Purification
98.00%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
576.77
Solubility
DMSO: 5mg/mL (8.67mM) Need ultrasonic
(<1mg/ml refers to the product slightly soluble or insoluble)
Formula
C34H48N4O4
SMILES
CCC1=C(C(NCC2=C(C)C=C(C)NC2=O)=O)C(C=C(C3CCN(C(C)C)CC3)O4)=C4C=C1N(C5CCOCC5)CC
CAS Number
2098546-05-3
Target & IC50
EZH2: ic50 6nM
In Vitro
EBI-2511 shows a dose-dependent inhibition on the tumor growth, resulting in 28% (10mg/kg), 83% (30mg/kg), and 97% (100mg/kg) reduction in tumor size. There are no significant changes in body weights of all treatment, groups are observed. At the same dosage level, EBI-2511 displays a superior anti-tumor efficacy to EPZ-6438 (P<0.01).

Structure of EBI-2511, inhibitor

EBI-2511 Inhibitor – Cat# MBS5754813

Product References and Citations for EBI-2511, inhibitor

Lu B, et al. Discovery of EBI-2511: A Highly Potent and Orally Active EZH2 Inhibitor for the treatment,of Non-Hodgkin's Lymphoma. ACS Med Chem Lett. 2018 Jan 29;9(2):98-102.
Lu B, et al. Discovery of EBI-2511: A Highly Potent and Orally Active EZH2 Inhibitor for the treatment,of Non-Hodgkin's Lymphoma. ACS Med Chem Lett. 2018 Jan 29;9(2):98-102.

Other Notes

Small volumes of EBI-2511, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for EBI-2511 purchase

MBS5754813 is an inhibitor targeting EBI-2511.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000